EA201200538A1 - Арабиногалактан для повышения приобретенного иммунного ответа - Google Patents

Арабиногалактан для повышения приобретенного иммунного ответа

Info

Publication number
EA201200538A1
EA201200538A1 EA201200538A EA201200538A EA201200538A1 EA 201200538 A1 EA201200538 A1 EA 201200538A1 EA 201200538 A EA201200538 A EA 201200538A EA 201200538 A EA201200538 A EA 201200538A EA 201200538 A1 EA201200538 A1 EA 201200538A1
Authority
EA
Eurasian Patent Office
Prior art keywords
immune response
acquired immune
arabinogalaktan
improve acquired
improve
Prior art date
Application number
EA201200538A
Other languages
English (en)
Other versions
EA024010B1 (ru
Inventor
Кевин К. Оуэн
Улла Фрайтас
Брайан Родригес
Джей Удани
Original Assignee
Лонца Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лонца Лтд filed Critical Лонца Лтд
Publication of EA201200538A1 publication Critical patent/EA201200538A1/ru
Publication of EA024010B1 publication Critical patent/EA024010B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

В заявке описана композиция, содержащая арабиногалактан, для повышения приобретенного иммунного ответа на чужеродный антиген (антигены). В заявке также описан набор для вакцинации, включающий композицию, которая содержит арабиногалактан и вакцину.
EA201200538A 2009-09-30 2010-09-29 Арабиногалактан для повышения приобретенного иммунного ответа EA024010B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24720409P 2009-09-30 2009-09-30
EP09014788A EP2327411A1 (en) 2009-11-27 2009-11-27 Arabinogalactan as immune enhancer
PCT/EP2010/005940 WO2011038898A1 (en) 2009-09-30 2010-09-29 Arabinogalactan for enhancing the adaptive immune response

Publications (2)

Publication Number Publication Date
EA201200538A1 true EA201200538A1 (ru) 2012-11-30
EA024010B1 EA024010B1 (ru) 2016-08-31

Family

ID=41667495

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201200538A EA024010B1 (ru) 2009-09-30 2010-09-29 Арабиногалактан для повышения приобретенного иммунного ответа

Country Status (9)

Country Link
EP (3) EP2327411A1 (ru)
JP (1) JP5844261B2 (ru)
KR (1) KR101787124B1 (ru)
AU (1) AU2010301525B2 (ru)
EA (1) EA024010B1 (ru)
ES (1) ES2593114T3 (ru)
NZ (1) NZ599077A (ru)
TW (1) TW201110978A (ru)
WO (1) WO2011038898A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784844B2 (en) 2009-09-30 2014-07-22 Lonza Ltd. Arabinogalactan for enhancing the adaptive immune response
JP6181121B2 (ja) * 2009-09-30 2017-08-16 ロンザ リミテッドＬｏｎｚａ Ｌｉｍｉｔｅｄ 適応性免疫応答を向上させるためのアラビノガラクタン
FR2969926B1 (fr) * 2011-01-04 2017-03-10 Elicityl Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
US9393259B2 (en) 2013-03-21 2016-07-19 Lonza Ltd. Composition comprising arabinogalactan and polyphenols from larch trees

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427530A (en) 1982-02-08 1984-01-24 Exxon Research And Engineering Co. Aromatic pitch derived from a middle fraction of a cat cracker bottom
US5756098A (en) 1995-12-12 1998-05-26 The University Of Montana Methods for the extraction of phytochemicals from fibrous plants in the absence of solvent
US6303584B1 (en) * 1996-11-20 2001-10-16 The University Of Montana Water soluble lipidated arabinogalactan
US6767546B1 (en) * 2001-08-17 2004-07-27 The United States Of America As Represented By The Secretary Of Agriculture Use of echinacea as a feed additive to enhance protection against coccidiosis
RU2519051C2 (ru) * 2008-06-25 2014-06-10 Брааш Биотех Ллк Композиции и способы для улучшенной иммуногенности соматостатина в лечении дефицита гормона роста и инсулиноподобного фактора роста

Also Published As

Publication number Publication date
EP2482826A1 (en) 2012-08-08
EP2482826B1 (en) 2016-07-13
JP2013506625A (ja) 2013-02-28
EP3081218A1 (en) 2016-10-19
KR101787124B1 (ko) 2017-10-18
AU2010301525B2 (en) 2016-11-17
EA024010B1 (ru) 2016-08-31
WO2011038898A1 (en) 2011-04-07
ES2593114T3 (es) 2016-12-05
NZ599077A (en) 2015-01-30
TW201110978A (en) 2011-04-01
KR20120091157A (ko) 2012-08-17
AU2010301525A1 (en) 2012-04-19
JP5844261B2 (ja) 2016-01-13
EP2327411A1 (en) 2011-06-01

Similar Documents

Publication Publication Date Title
EA201001491A1 (ru) Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
CY1120413T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
EA201291157A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
MX2011011505A (es) Vacuna neumococica y usos de la misma.
MY169837A (en) Immunogenic compositions of staphylococcus aureus antigens
EA201291105A1 (ru) Пероральная вакцина, содержащая антиген и агонист toll-подобного рецептора
EA200901340A1 (ru) Вакцина
EA201691348A1 (ru) Однофлаконные вакцинные составы
MY150706A (en) Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
WO2012027365A3 (en) Targeted multi-epitope dosage forms for induction of an immune response to antigens
CL2012003299A1 (es) Vacuna que comprende uno o mas antigenos, uno o mas oligonucleotidos inmunoestimuladores aislados y colesterol; metodo para inducir una respuesta inmune antigeno específica en un sujeto que necesita de la misma.
EA201291117A1 (ru) Иммуногенные композиции и способы лечения неоплазии
UA118332C2 (uk) Білок, що зв'язує антиген cd27l
EA201391240A1 (ru) Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza
EA201391597A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
TR201802380T4 (tr) Benzonaftiridin içeren aşılar.
ME01199B (me) Nove kompozicije adjuvanta
BRPI0520330B8 (pt) adjuvante a base de ácido polinosínico-policitidílico
MX352478B (es) Proteina vp6 de la capside de norovirus y rotavirus para el uso como vacuna combinada.
WO2013054199A3 (en) Cmv antigens and uses thereof
MX2008016036A (es) Vacuna viral recombinante.
UY36395A (es) Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso.
PH12015500956B1 (en) Novel mucosal adjuvants and delivery systems
PT1951300E (pt) Modificação do equilíbrio de th1/th2 em vacinas da influenza fragmentadas com adjuvantes
CL2012003458A1 (es) Vector que comprende un polipeptido antigénico de campylobacter; composicion farmacéutica que comprende dicho vector; uso del vector para mejorar respuesta inmune del sujeto al polipéptido antigénico.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM